A patient with myelodysplastic syndrome studied by GTG-banding and fluorescent in situ hybridization (FISH)

Cytobios

Volumn 1998, Issue 376, 1998, Pages 121-128

  Mark, Hon Fong L ^a,b   Mark, Yvonne ^b   Sotomayor, Edgar ^b   Sambandam, Sundaresan ^b  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Chromosome 10 marker; Fluorescent in situ hybridization; GTG banding; Trisomy 8

Indexed keywords

AGED; ARTICLE; CASE REPORT; CHROMOSOME BANDING PATTERN; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GENETICS; HUMAN; KARYOTYPING; LUNG TUMOR; MALE; METAPHASE; MYELODYSPLASTIC SYNDROME;

AGED; CHROMOSOME BANDING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LUNG NEOPLASMS; MALE; METAPHASE; MYELODYSPLASTIC SYNDROMES; TRANSLOCATION, GENETIC;

EID: 0031987103     PISSN: 00114529     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. ABUELO D., Mark H. F. L. and Bier J. 1995. Developmental delay caused by a supernumerary chromosome, inv dup (15), identified by fluorescent in situ hybridization. Clin. Pediatrics 34 223-6.
2. ESTALILLA O., Rintels P. and Mark H. F. L. 1998. Trisomy 10 in leukemia. Cancer Genet. Cytogenet. 101 68-71.
3. HEIM S. and Mitelman F. 1995. Cancer cytogenetics. Wiley-Liss, New York.
4. ISCN. 1995. An international system for human cytogenetic nomenclature. S. Karger, Basel, Switzerland.
5. MARK H. F. L. 1994a. Fluorescent in situ hybridization as an adjunct to conventional cytogenetics. Ann. Clin. Lab. Sci. 24 153-63.
6. MARK H. F. L. 1994b. Bone marrow cytogenetics and hematologic malignancies. The Cytogenetics Symposia, Burbank, California, U.S.A. The Association of Cytogenetic Technologists.
7. MARK H. F. L., Meyers-Seifer C. H., Seifer D., DeMoranville B. and Jackson I. M. 1995a. Assessment of sex chromosome composition using FISH as an adjunct to GTG-banding. Ann. Clin. Lab. Sci. 25 402-8.
8. MARK H. F. L., Sikov W., Safran H., King T. C. and Griffith R. C. 1995b. Fluorescent in situ hybridization for assessing the proportion of cells with trisomy 4 in a patient with acute non-lymphoblastic leukemia. Ann. Clin. Lab. Sci. 25 330-5.
9. MARK H. F. L., Bayleran J. K., Seifer D. B. and Meyers-Seifer C. H. 1996. A combined cytogenetic and molecular approach for diagnosing delayed puberty. Clin. Pediatrics 35 62-6.
10. MARK H. F. L., Huth A., Santoro K., Ferreira K. and Barker B. 1997a. Sequential flow cytometry and FISH for the study of formalin-fixed paraffin-embedded breast cancer tissues. Cancer Genet. Cytogenet. 98 1-5.
11. MARK H. F. L., Mills D., Santoro K., Quddus M. and Lathrop J. C. 1997b. Fluorescent in situ hybridization (FISH) analysis of cervical smears: a pilot study of 20 cases. Ann. Clin. Lab. Sci. 27 224-9.
12. MARK H. F. L., Gray Y., Sotomayor E. and Joseph P. 1998 Trisomy 9 in a patient with secondary AML detected by fluorescent in situ hybridization (FISH). Pathobiology. In press.
13. MOORHEAD P. S., Nowell P. C., Mellman W. I., Battips D. M. and Hungerford D. A. 1960. Chromosome preparation of leukocytes cultured from human peripheral blood. Expl Cell Res. 20 613-6.
14. RINTELS P., Gray Y. and Mark H. F. L. 1997. Translocation 2;19 in a patient with probable relapsed AML. Pathobiology 65 223-8.
15. ROONEY D. E. and Czepulkowski B. H. 1992. Human cytogenetics: a practical approach. Vol 2. Malignancy and acquired abnormalities. Oxford University Press, New York.
16. SEABRIGHT M. 1971. A rapid banding technique for human chromosomes. Lancet 2 971-2.
17. SUMNER A. T., Evan H. J. and Buckland R. A. 1971. New technique for distinguishing between hu-chromosome. Nature 232 31-2.
18. YOUNG C., DiBenedetto I., Glasser L. and Mark H. F. L. 1996. A Philadelphia chromosome positive CML patient with a unique translocation studied via GTG-banding and fluorescent in situ hybridization. Cancer Genet. Cytogenet. 89 157-62.